STOCK WARRANTS (Details Narrative) - USD ($) |
2 Months Ended | 6 Months Ended | |
|---|---|---|---|
Mar. 31, 2020 |
Jun. 30, 2021 |
Jun. 30, 2020 |
|
| Class of Warrant or Right [Line Items] | |||
| Proceeds from the exercise of warrants | $ 2,000 | $ 7,474,000 | |
| Warrants from Feb 2020 Financing [Member] | |||
| Class of Warrant or Right [Line Items] | |||
| Number of exercised warrants | 10,800,000 | 3,400 | 10,800,000 |
| Exercise price (in dollars per share) | $ 0.57 | $ 0.57 | $ 0.57 |
| Proceeds from the exercise of warrants | $ 6,200,000 | $ 2,000 | $ 6,200,000 |
| Warrants from Nov 2019 Financing [Member] | |||
| Class of Warrant or Right [Line Items] | |||
| Number of exercised warrants | 2,300,000 | 2,300,000 | |
| Exercise price (in dollars per share) | $ 0.57 | $ 0.57 | |
| Proceeds from the exercise of warrants | $ 1,300,000 | $ 1,300,000 | |
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The cash inflow associated with the amount received from holders exercising their stock warrants. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|